June 30, 2021

Towards a Patient-Focused Drug Development Ecosystem: Adoption of Core Outcome Sets

DIA 2021 Global Annual Meeting



Faegre Drinker Consulting Director Allison Martin joined a panel of agency officials and industry professionals to discuss the ecosystem of patient-focused drug development and patient-focused outcome measures. The panel explored efforts by regulators and the patient community to develop core outcome sets and discussed how these can be leveraged to support drug development programs and facilitate shared learnings. Allison’s presentation, from the perspective of UsAgainstAlzheimer’s AD PACE (Alzheimer’s Disease Patient and Caregiver Engagement) initiative, explored the need for clinical trial outcome assessments that measure what matters most to Alzheimer’s patients and caregivers.

Services and Industries

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.